Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound – DL39624

This document is a response to comments regarding the proposed policy on amniotic and placental derived product injections/applications for non-wound musculoskeletal indications (DL39624). The response article itself does not contain specific coverage indications, limitations, documentation requirements, or frequency limits; consult the final DL39624 policy and participating MACs for definitive coverage criteria.

"Amniotic and placental derived product injections and/or applications for musculoskeletal (non-wound) indications are the subject of the proposed policy referenced in this document."

Sign up to see full coverage criteria, indications, and limitations.